Japanese Study calls for Global Ban on ‘Contaminated’ Blood Donations from COVID-Vaccinated Individuals

A major Japanese study has called for a global ban on blood donations from COVID-vaccinated individuals to prevent further expansion of blood contamination in the blood supply.

In the pre-print study <Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures>, the researchers cite injuries caused by genetic vaccinations to urge regulators to ban COVID-vaccinated people donating blood due to the risks involved.

Japan links ‘Safe & Effective’ Covid-19 shots to 201 Dangerous Diseases

The health injuries caused by genetic vaccination are already extremely serious, and it is high time that countries and relevant organizations take concrete steps together to identify the risks and to control and resolve them.

Table 1 of the paper summarizes the six major concerns identified by the researchers with the use of blood products derived from gene vaccine recipients.

We have copied the contents of Table 1 below.

1. Spike protein contamination

The spike protein, which is the antigen of SARS-CoV-2 and genetic vaccines, has already been found to have various toxicities, including effects on red blood cells and platelet aggregation, amyloid formation, and neurotoxicity.

It is essential to recognise that the spike protein itself is toxic to humans. It has also been reported that the spike protein can cross the blood-brain barrier. Therefore, it is essential to remove the spike protein derived from the gene vaccine itself from blood products.

High Recorded Mortality in Countries categorized as “Covid-19 Vaccine Champions”

2. Contamination with amyloid aggregates and microthrombi formed by spike proteins

It is not yet clear how the amyloid aggregates and microthrombi formed by the spike proteins develop into visible thrombi.

However, once formed, amyloid aggregates may not be readily cleared and therefore need to be removed from blood products. These amyloid aggregates have also been shown to be toxic.

3. Events attributable to decreased donor immune system and immune abnormalities due to immune imprinting or class switch to IgG4, etc. resulting from multiple doses of genetic vaccines

When the immune function of a donor is impaired by gene vaccination, there is a risk that the donor has some (subclinical) infectious disease or is infected with a pathogenic virus and has developed viremia or other conditions, even if the donor has no subjective symptoms.

For this reason, healthcare professionals who perform surgical procedures, including blood sampling and organ transplantation, as well as using blood products, should manage the blood of genetic vaccine recipients with care to prevent infection through blood. It will also be necessary to inform all healthcare professionals of these risks.

4. Lipid nanoparticles (“LNPs”) and pseudouridinated mRNA (mRNA vaccines only)

In the case of mRNA vaccines, LNPs and pseudouridinated mRNA may remain in the blood of recipients if blood is collected without a sufficient deferral period after gene vaccination. LNPs are highly inflammatory and have been found to be thrombogenic themselves, posing a risk to transfusion recipients.

LNP’s themselves have potent adjuvant activity and are at risk of inducing Adjuvant-Induced Autoimmune Syndrome (“ASIA syndrome”).

An additional risk is that if the pseudouridinated mRNA is incorporated into the recipient’s blood while still packaged in LNP’s, additional spike protein may be produced in the recipient’s body.

5. Contamination with aggregated red blood cells or platelets

The spike protein causes red blood cells and platelets to aggregate and therefore these aggregates will be carried into the recipient’s blood unless they are removed from the blood product.

6. Memory B cells producing IgG4 and IgG4 produced from them

Large amounts (serum concentration typically above 1.25–1.4 g/L) of non-inflammatory IgG4-positive plasma cells can cause chronic inflammation such as fibroinflammatory disease.

IgG4 is an antibody and is the acronym for immunoglobulin G4.

Earlier in the paper, the authors wrote that long-term exposure to a specific identical antigen (in this case, spike protein) causes immunoglobulins.

Japan declares Covid-19 Vaccine Most Deadly Drug in History of Humankind

For these to become IgG4 and some of the B cells that produce them are likely to differentiate into memory B cells that survive in the body for a sustained period, the immune dysfunction of genetic vaccine recipients is expected to be prolonged.

More details on these points are expected to be revealed in the future. The researchers also make suggestions for specific tests, testing methods and regulations to deal with these risks.

News Punch / ABC Flash Point News 2024.